France· FR:65395919
ATROPINE SULFATE RENAUDIN 1 mg/mL, solution injectable en ampoule
A medicinal product containing sulfate d'atropine, registered in France by LABORATOIRE RENAUDIN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SULFATE D'ATROPINE
- Manufacturer
- LABORATOIRE RENAUDIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093643193510 ampoule(s) bouteille en verre de 1 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sulfate d'atropine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomActonorm oral powderWallace Manufacturing Chemists Ltd
- United StatesATROPEN Auto-InjectorMeridian Medical Technologies LLC
- GermanyAtropin AccordAccord Healthcare B.V.
- FinlandAtropinOrifarm Oy
- SwitzerlandAtropin Sulfat Aguettant 0.5 mg/5 ml, solution injectable en seringue pré-remplieAguettant Suisse SA
- BelgiumAlcon Atropine 0.5 %Alcon
- NorwayAtropinEvolan Pharma AB
- CanadaALCON ATROPINEALCON CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Atropin Accord, Atropinsulfat Aguettant
- Belgium · Atropine Alcon, Atropine Sulfate Aguettant
- Bulgaria · Атропин Вижън, Атропин Софарма
- Cyprus · Atropine Sulfate, Atropine Αρητη
- Czechia · Atropin Bbp, Atropin-Pos
- Germany · Atropin Accord, Atropin-Pos
- Denmark · Atropin Abboxia, Atropin Aguettant
- Estonia · Atropine Auxilia, Atropine Basi
- Spain · Atropina Accord, Atropina Aguettant
- Finland · Atropin Abboxia, Atropin Aguettant
- United Kingdom (Northern Ireland) · Atrophine Sulfate Wockhardt Uk, Atropine Aspire
- Greece · Atropine Sulfate Bradex, Atropine Sulfate Cooper
- Hungary · Atropine Sulphate Noridem, Atropinum Sulfuricum Egis
- Ireland · Atropine Sulfate Aguettant, Minims
- Iceland · Atropin Abboxia, Atropin Viatris
- Italy · Atropina Farmigea, Atropina Solfato Accord
- Liechtenstein · Ryjunea
- Lithuania · Atropine Sulfate Basi
- Luxembourg · Alcon, Atropine (Sulfate) Noridem
- Latvia · Atropine Sopharma, Atropine Sulfate Basi
- Malta · Minims
- Netherlands · Atorvastatina Cf, Atropinesulfaat Accord
- Norway · Atropin Abboxia, Atropin Aguettant
- Poland · Atropinum Sulfuricum Wzf, Bellapan
- Portugal · Atropina Accord, Atropina Aguettant
- Romania · Sulfat De Atropină Accord, Sulfat De Atropină Evolan
- Sweden · Atropin Abboxia, Atropin Aguettant
- Slovakia · Atropin Bbp, Atropine Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e77d9a60-ee96-4fcd-b7cb-2974626d9eeb GET /v1/drugs/e77d9a60-ee96-4fcd-b7cb-2974626d9eeb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65395919",
"date_amm": "1996-01-16",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "SULFATE D'ATROPINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about sulfate d'atropine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.